ID   HSC 62
AC   CVCL_G046
AS   CVCL_AK38
SY   HSC-62; HSC62; GM13023
DR   CLO; CLO_0013995
DR   BioSample; SAMN00802020
DR   Coriell; GM13023
DR   Wikidata; Q54896374
RX   PubMed=6809308;
RX   PubMed=7994019;
RX   PubMed=12065746;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.8488-1G>A (IVS19-1G>A); ClinVar=VCV000038164; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=12065746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
RX   PubMed=6809308;
RA   Ishida R., Buchwald M.;
RT   "Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking
RT   and alkylating agents.";
RL   Cancer Res. 42:4000-4006(1982).
//
RX   PubMed=7994019; DOI=10.1182/blood.V84.12.3995.bloodjournal84123995;
RA   Liu J.M., Buchwald M., Walsh C.E., Young N.S.;
RT   "Fanconi anemia and novel strategies for therapy.";
RL   Blood 84:3995-4007(1994).
//
RX   PubMed=12065746; DOI=10.1126/science.1073834;
RA   Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q.,
RA   de Die-Smulders C.E.M., Persky N., Grompe M., Joenje H., Pals G.,
RA   Ikeda H., Fox E.A., D'Andrea A.D.;
RT   "Biallelic inactivation of BRCA2 in Fanconi anemia.";
RL   Science 297:606-609(2002).
//